lj ºñ´¢±â°ú

ÄÁÅÙÃ÷ ¹Ù·Î°¡±â

º»¹®¹Ù·Î°¡±â

·Î°í

¿¤Á¦À̺ñ´¢±â°ú ȨÀ¸·Î À̵¿
¿¬¼¼ÀÇ´ë È®´ë Á¶·çÁßÁ¡
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
È®´ë, Á¶·ç ÁßÁ¡ LJ4MÄÚ¾î È®´ë¼ö¼úljÁ¶·ç¼ö¼ú¹ý
  • ±¹Á¦ÇÐȸ
    50ȸ¹ßÇ¥
  • ±¹Á¦ÇÐȸ
    ÃÖ¿ì¼ö»ó
  • ¼ö¸¹Àº
    ¼ö¼ú°æÇè
  • ÀÇ»çÃ¥ÀÓ
    ¼ö¼úÈıâ
  • ¼ö¼ú±â¹ý
    °³¹ß¹ßÇ¥
LJ Ư¡ | ±â°ü¼Ò°³



LJºñ´¢±â°ú´Â È®´ë, Á¶·ç¼ö¼ú ÁßÁ¡ ³²¼ººñ´¢±â°úÀÔ´Ï´Ù. Àå¼ö¿¬¿øÀåÀº ¿¬¼¼´ëÇб³ Á¹¾÷, ¿¬¼¼´ë ¼¼ºê¶õ½º º´¿ø¿¡¼­ Àü¹®ÀǸ¦ ÃëµæÇÏ¿´½À´Ï´Ù. 20³â°£ ¹«»ç°í(ÀÇ·á»ç°í 0¸í) °æ·ÂÀ¸·Î ¿À·ÎÁö À½°æÈ®´ë, Á¶·ç¼ö¼ú ¸¸À» ÁßÁ¡ÀûÀ¸·Î Áø·áÇÏ¿´°í 100% ¸ðµç ¼ö¼ú¿¡¼­ ÁøÇǸ¸À» ÀÌ¿ëÇÑ È®´ë¼ú°ú Á¶·ç¼ö¼úÀ» ½ÃÇàÇÏ¿´½À´Ï´Ù. ¼¼°èÀû ±ÇÀ§ÀÇ ÇØ¿Ü ±¹Á¦ÇÐȸ¿Í ¹Ì±¹ µî ¼±Áø±¹¿¡¼­ 90% ÀÌ»ó ´ëºÎºÐ¿¡¼­ ½ÃÇàµÇ´Â µ¿Á¾ÀúÀåÁøÇÇ¿Í À½°æ »Ñ¸®ºÎºÐ ºÎºÐ Àý°³¸¦ ÅëÇÑ À½°æÈ®´ë¼úÀ» ±âº»À¸·Î Àå¼ö¿¬¿øÀåÀÌ 4MÄÚ¾î È®´ë¼ú, Ãß°¡ÁøÇÇ Á¶·ç¼ö¼úÀ» °³¹ßÇÏ¿© 10,000¸í ÀÌ»ó ¼ö¼úÇÏ¿´°í À̸¦ 50Â÷·Ê ÀÌ»ó ÇØ¿ÜÇÐȸ¿¡ ¹ßÇ¥ÇÏ¿´½À´Ï´Ù.


¸í½Ç»óºÎÇÏ°Ô °¡Àå ±ÇÀ§ ÀÖ´Â »óÀ§ ºñ´¢±â°ú ¹× ¼º±â´É ±¹Á¦ Çмú´ëȸ¸¦ ÃѸÁ¶óÇÑ ¼¼°è ¼º±â´ÉÇÐȸ(ISSM), À¯·´ ¼º±â´ÉÇÐȸ(ESSM), ¾Æ-Å ¼º±â´ÉÇÐȸ(APSIR), ¼¼°è ¼ºÇÐȸ(WAS), ¼¼°è ³²¼ºÇÐȸ (WCMH), À¯·´ ¼ºÇÐȸ(EFS), ºÏ¹Ì ¼º±â´ÉÇÐȸ(SMSNA), ¹Ì±¹ ºñ´¢±â°úÇÐȸ(WSAUA)µî¿¡¼­ LJÀÇ·áÁøÀº 4MÄÚ¾î À½°æÈ®´ë¼ú (±¸ 3M¼ö¼ú)°ú Á¶·ç¿¡ °üÇؼ­¸¸ 50¿© Â÷·ÊÀÇ (±¸Ã¼ÀûÀÎ ¹ßÇ¥ Á¦¸ñ ¹× Àå¼Ò, ÇÐȸÁö °ÔÀç µîÀº ÇÐȸ¹ßÇ¥ Äڳʿ¡¼­ ±¸Ã¼Àû È®ÀÎ °¡´ÉÇÔ) ±¹Á¦ÇÐȸ ¹ßÇ¥¸¦ ½ÃÇàÇÏ¿´½À´Ï´Ù.

¶ÇÇÑ Ãß°¡ÁøÇÇÁ¶·ç¼ö¼ú(ÁøÇÇÀ̽ÄÁ¶·ç¼ö¼ú Ãß°¡À̽Ĺý)À» 2007³â °¡Àå ¸ÕÀú °³¹ßÇÏ¿© ¼ö õ·ÊÀÇ ¼ö¼ú°æÇèÀ» ´©ÀûÇÑ ÈÄ 2015³â ½ºÆäÀÎ ¸¶µå¸®µå¿¡¼­ °³ÃÖµÈ ICSM(International Consultation of Sexual Medicine) ¼¼°è ¼ºÀÇÇÐ ÇÐȸ ¿¡¼­ »ç»ó óÀ½À¸·Î ÁøÇÇÀ̽ÄÁ¶·ç¼ö¼ú Ãß°¡À̽Ĺý¿¡ °üÇÑ ¼öõ·ÊÀÇ °æÇè°ú ¼ö¼ú±â¹ý¿¡ ´ëÇÑ ¹ßÇ¥¸¦ ÇÏ¿´½À´Ï´Ù. ÀÌÈÄ 2017³â ¼¼°è ¼ºÇÐȸ(Was, Congress of the World Association of Sexology)°¡ üÄÚ(Czech Republic) ÇÁ¶óÇÏ(Prague)¿¡¼­ °³ÃֵǾú´Âµ¥ ÀÌ °÷¿¡¼­ ¶Ç´Ù½Ã ÁøÇÇÀ̽ÄÁ¶·ç¼ö¼ú Ãß°¡À̽ĹýÀÇ ¸®Æ÷Æ® (Report of Penile Surgery Transplanted with Allogenic Dermal Graft for Treatment of Premature Ejaculation) ¸¦ ¹ßÇ¥ÇÏ¿´°í ¸¹Àº ÇØ¿ÜÀÇ Àü¹®°¡µé·ÎºÎÅÍ È£ÆòÀ» ¹Þ¾Ò½À´Ï´Ù.

À½°æÈ®´ë¼ö¼ú°ú Á¶·ç¼ö¼úÀÇ ±âº»ÀÌ µÇ´Â 4MÄÚ¾î À½°æÈ®´ë¼ú (±¸ 3M¼ö¼ú)·Î 2012 À¯·´ ¼º±â´ÉÇÐȸ (ESSM)¿¡¼­´Â 3MÀ½°æÈ®´ë¼ö¼ú¿¡ ´ëÇÑ º¸°í ¶ó´Â Á¦¸ñÀ¸·Î º£½ºÆ® ¼ö¼ú ¹ßÇ¥»ó (Award for Best Surgical Presentation)À» ¼ö»óÇÏ¿´°í ¶Ç ÇÑ°¡Áö ȹ±âÀûÀÎ ¼ö¼ú±â¹ýÀ» LJÀÇ·áÁøÀÌ Ãß°¡ÇÏ¿© 4MÄÚ¾î À½°æÈ®´ë¼úÀ» ¿Ï¼ºÇß½À´Ï´Ù. ´ç½Ã ³²¼º¼ö¼ú ºÐ¾ß(Surgery field)¿¡¼­´Â À¯ÀÏÇÏ°Ô ¼ö»óÀ» Çߴµ¥ ÀÌ°ÍÀº º»¿ø À½°æÈ®´ë¼ú ±â¹ýÀÇ ¾ÈÀü¼º°ú Ź¿ùÇÑ ¼ö¼ú È¿°ú, ÇÕ¸®Àû ±â¹ý, ȹ±âÀûÀÎ ¼ú±â µîÀÌ È£ÆòÀ» ¹Þ¾Ò±â ¶§¹®ÀÔ´Ï´Ù. ¹«·Á 40Â÷·Ê ÀÌ»ó 3MÈ®´ë¼úÀ» ²ÙÁØÈ÷ ÇØ¿Ü ±¹Á¦ÇÐȸ ¹ßÇ¥·Î °ËÁõ°úÁ¤À» °ÅÄ£ ÈÄ °á±¹ º£½ºÆ® ¼ö¼ú ¹ßÇ¥»óÀ» ¼ö»óÇÏ¿´½À´Ï´Ù.

Àå¼ö¿¬¿øÀåÀº LJÈ®´ë¼úÀ» ¸ðÅ·ΠÇÏ¿© ÁøÇÇÀ̽ÄÁ¶·ç¼ö¼úÀ» °³¹ßÇÏ¿© ¼öõ·Ê¸¦ ½ÃÇàÇÏ¿´°í À̸¦ ¾÷±×·¹À̵å ÇÏ¿© Ãß°¡ÁøÇÇ Á¶·ç¼ö¼ú(ÁøÇÇÀ̽ÄÁ¶·ç¼ö¼ú Ãß°¡À̽Ĺý)À» ¿Ï¼ºÇÏ¿´½À´Ï´Ù. ÁøÇÇÀ̽ÄÁ¶·ç¼ö¼úÀÇ °³³äÁ¶Â÷ ¾ø´ø 2007³âºÎÅÍ Ã³À½À¸·Î ½ÃÇàÇÏ¿© 2015³â ½ºÆäÀÎ ¸¶µå¸®µå¿¡¼­ °³ÃÖµÈ ICSM(International Consultation of Sexual Medicine) ¼¼°è ¼ºÀÇÇÐ ÇÐȸ¿¡¼­ ÁøÇÇÁøÇÇ Á¶·ç¼ö¼ú Ãß°¡À̽Ĺý¿¡ ´ëÇÑ ¼ö õ·ÊÀÇ °æÇè°ú ¼ö¼ú±â¹ý¿¡ ´ëÇÑ ¹ßÇ¥ÇÏ¿´½À´Ï´Ù. ÀÌÈÄ 2017³â ¼¼°è ¼ºÇÐȸ(Was, Congress of the World Association of Sexology)°¡ üÄÚ(Czech Republic) ÇÁ¶óÇÏ(Prague)¿¡¼­ °³ÃֵǾú´Âµ¥ ÁøÇÇÀ̽ÄÁ¶·ç¼ö¼ú Ãß°¡À̽ĹýÀ» ¹ßÇ¥ÇÏ¿© È£Æò¹Þ¾Ò½À´Ï´Ù.


?À¯·´ ÇÁ¶û½º Æĸ®¿¡¼­ °³ÃÖµÈ ¼¼°è ¼ºÀÇÇÐȸ(ICSM)¿¡¼­µµ LJÀÇ·áÁøÀº À½°æÈ®´ë¼ú ½ÃÇà½Ã ºÎÀÛ¿ëÀ» ÁÙÀÌ´Â ±â¹ý¿¡ ´ëÇÑ ¿¬±¸ (¿øÁ¦: Consideration on reducing complication rate after phalluplasty), ¾ÈÀü¼º°ú È¿À²¼ºÀ» °¡Áø À½°æÀçÈ®´ë¼ö¼ú¿¡ °üÇÑ ¿¬±¸(¿øÁ¦: Consideration on the safest and the most effective methods for second augmentation surgery) µîµî ½ÇÁ¦ ¼ö¼úÀÇ ¾ÈÀü¼º, ¼ö¼úÈ¿°ú Áõ´ë, ¼ö¼ú ÀÚüÀÇ ÇÕ¸®ÀûÀÎ °úÁ¤ µî¿¡ °ü·ÃµÈ ºÎºÐÀ» ÁýÁßÀûÀ¸·Î ¹ßÇ¥ÇÏ¿´°í ¼ö ½ÊÂ÷·Ê ÇмúÁö¿¡ °ÔÀç µÇ¾ú½À´Ï´Ù.

Àå¼ö¿¬¿øÀåÀº À½°æÈ®´ë¼ú Àü¿ë ¸®Æ®·ºÅÍ °³¹ß ¹ßÇ¥, ´ÙÀ̾Ƹóµå ÇÔ¸ôÀ½°æ±³Á¤¹ý °³¹ß , ¸ÖƼ ·¹ÀÌ¾î ¼ö¼ú¹ýÀÇ °³¹ß, ¼ö¼ú ¸¸Á·µµ¸¦ À¯ÁöÇϱâ À§ÇÑ ³²¼º¼ö¼ú ¹× Ä¡·á¹ýÀÇ ¹ßÇ¥, ȹ±âÀûÀ¸·Î Å©±â¸¦ ÁÙÀÎ Àý°³¹æ¹ý °³¹ß ¹× ±¹Á¦ÇÐȸ ¹ßÇ¥, Á¶·çÄ¡·á ¹× ¹ß±â·Â °³¼± °ü·Ã ±¹Á¦ÇÐȸ ¹ßÇ¥ µî ½ÇÁ¦ ¼ö¼ú±â¹ý°ú ¼ö¼ú°á°ú¸¦ ¾÷±×·¹À̵å ÇÏ´Â ¹æ¹ýµé, ¼ö¼úÀÇ ¾ÈÀü¼ºÀ» È®½ÇÈ÷ È®º¸ÇÏ´Â ³»¿ëµé¿¡ ´ëÇÑ ¹ßÇ¥¸¦ ÇÏ¿´½À´Ï´Ù.


´Ü¼øÇÑ µ¥ÀÌÅÍÀÇ ¹ßÇ¥¸¦ ÇÏ´Â °ÍÀÌ ¾Æ´Ï¶ó ½ÇÁ¦ ¼ö¼ú±â¹ý ÀÚü¸¦ ¾÷±×·¹À̵å ÇÏ¿© ¹ßÇ¥ÇÏ¿´À¸¸ç µû¶ó¼­ ½ÇÁ¦ ¼ö¼ú ½Ã¿¬ Àå¸éÀ» ÅëÇÑ ¹ßÇ¥ (ISSIR)³ª ½ÇÁ¦ ±æÀÌ¿¬Àå¼ö¼ú¿¡ °ü·ÃµÈ ´ÙÃþºÀÇÕ ±â¹ý (ISSIR, APSIR), ´ÙÀ̾Ƹóµå ¼ö¼ú¹ý (WAS, ISSIR), ¼º±âÈ®´ë¼ú Àü¿ë¸®Æ®·ºÅÍ °³¹ß ¹ßÇ¥(ICSM, APSIR), ¼ö¼ú ÈÄ ºÎÀÛ¿ë(¿°Áõ°¡´É¼º) ȹ±âÀû °³¼± ¹æ¹ý ¿¬±¸ (ICSM, EFS, SMSNA), À½°æ ÀçÈ®´ë¼ú¿¡¼­ °¡Àå ¾ÈÀüÇÏ°í È¿À²ÀûÀÎ ¹æ¹ý¿¡ ´ëÇÑ ¿¬±¸ ¹ßÇ¥ (ICSM), ¼ö¼ú Àü ÈÄ °úÁ¤¿¡ ´ëÇÑ Á¤È®ÇÑ ¿¹Ãø°ú ÀÌ¿¡ ´ëÇÑ ¼³¸í (ISSIR, ICSM, WAS, SMSNA), À½°æÈ®´ë¼ö¼ú°ú À̹°ÁúÁ¦°Å ¼ö¼úÀÇ µ¿½Ã ¼ö¼ú°á°ú¿¬±¸(EFS, ESSM), À½°æ¸¸°îÁõ°ú ³²ÀÚÈ®´ë¼ö¼úÀ» µ¿½Ã¿¡ Ä¡·áÇÏ´Â À§ÇÑ ¼ö¼ú¹ý ¿¬±¸(WSAUA) 14ȸ À¯·´¼º±â´ÉÇÐȸ (ESSM) ÀÌÅ»¸®¾Æ ¹Ð¶ó³ë°³ÃÖ, Á¶·çÁõ(premature ejaculation) ÇØ°á¹æ¹ý, 15ȸ (ESSM) ³×´ú¶õµå ¾Ï½ºÅ׸£´ã 3MÈ®´ë¼ö¼ú¹ý º£½ºÆ® ¹ßÇ¥»ó(ÃÖ¿ì¼ö¹ßÇ¥»ó)¼ö»ó µîµî ½ÇÁ¦ À½°æÈ®´ë¼ö¼úÀÇ °í°´¸¸Á·µµ¿Í ¼ö¼ú ¾ÈÀüµµ¿Í Á÷°áµÈ ºÎºÐ¿¡ ´ëÇØ ¸ðµç ¿ª·®À» ÁýÁßÇÏ¿© 4MÄÚ¾î º¹ÇÕÀ½°æÈ®´ë¼ú(±¸ 3MÈ®´ë¼ú)°ú Á¶·ç¼ö¼úÀ» ¿Ï¼º½ÃÄÑ¿Ô½À´Ï´Ù.

Àå¼ö¿¬¿øÀåÀº 2023³â 3¿ù±îÁö À½°æÈ®´ë¼ú°ú Á¶·ç¼ö¼úÀ» 10,000¸í ÀÌ»ó Áýµµ ÇÏ¿´½À´Ï´Ù. ÀÌ Åë°è¿¡´Â ¸¸°îÁõ ¼ö¼ú ´Üµ¶, Á¤°ü¼ö¼ú, Æ÷°æ¼ö¼ú, À̹°Áú Á¦°Å¼ö¼ú µîÀÇ ¾ÆÁÖ ÈçÇÏ°Ô ½ÃÇàµÇ´Â ¸¶ÀÌ³Ê ³²¼º¼ö¼úÀº Á¦¿ÜÇÑ °ÍÀÔ´Ï´Ù. ÀÌ ¼ö¼ú ÄÉÀ̽º ¼ö´Â ±¹¼¼Ã» ½Å°í ¹× ¼Òµæ¼¼ ½Å°í ¹× ±â³³ºÎ ±Ý¾× ±âÁØÀ¸·Î ±¹¼¼Ã»¿¡¼­µµ ȨÆäÀÌÁö¸¦ ±Ù°Å·Î Á¶»ç¿¡ È°¿ëÇϱ⠶§¹®¿¡ Àý´ë·Î °úÀåÇÒ ¼ö ¾ø´Â ¼öÄ¡ÀÔ´Ï´Ù. (Âü°í·Î Ÿ±â°üÀÇ ³²¼º¼ö¼ú OOO ·Ê´Â ÁöÁ¡ ÀÇ»çµé Àüü¿Í Æ÷°æ, Á¤°ü¼ö¼ú µîÀÇ ¸¶ÀÌ³Ê ³²¼º¼ö¼ú µé, ¿©À¯Áõ, Áö¹æÈíÀÔ±îÁö ¸ðµÎ Æ÷ÇÔÇÑ ¼öÄ¡·Î ÀÇ»ç 1ÀÎ´ç ¼ö¼ú °æÇèÄ¡´Â ¸Å¿ì Àû½À´Ï´Ù.)

ÀÌó·³ Àå¼ö¿¬¿øÀåÀº °³¿ø ÀÌ·¡ 20³â µ¿¾È À¯·Ê ¾øÀÌ ¸¹Àº ³²¼ºÈ®´ë¼ö¼ú(4MÄÚ¾î, ±¸3M¼ö¼ú), Á¶·ç¼ö¼ú °æÇèÀ» ´©ÀûÇÏ¿´°í ȹ±âÀûÀÎ È®´ë, Á¶·ç ¼ö¼ú±â¹ýÀÇ °³¹ß°ú ¹ßÇ¥¸¦ Çß½À´Ï´Ù. ÇöÁ¸ÇÏ´Â ÀÇ»çµé Áß ¼¼°è ¾îµð¿¡¼­µµ ÀúÈñ¸¸Å­ ¸¹Àº È®´ë, Á¶·ç¼ö¼ú °æÇèÀ» ¸¹ÀÌ °¡Áø ÀÇ»ç´Â º»ÀûÀÌ ¾ø½À´Ï´Ù. LJÀÇ È®´ë, Á¶·ç¼ö¼ú Èıâ 800ÆíÀº 3°³¿ù ÀÌÈÄÀÇ Èı⸸ ÀÖÀ¸¸ç 5³â ÀÌ»ó µÈ Èı⵵ »ó´ç ¼ö ÀÖ½À´Ï´Ù. 100% Á÷Á¢ ¼ö¼ú¹ÞÀº ºÐÀÌ ¾´ Èıâ ÀÓÀ» ÀÌÁÖÇü, Àå¼ö¿¬ ¿øÀåÀÌ Ã¥ÀÓÁö°í º¸ÁõÇÕ´Ï´Ù.

LJ´Â 20³â µ¿¾È ÇÑ°á°°ÀÌ È®´ë, Á¶·ç ÁßÁ¡ ºñ´¢±â°ú·Î ÇÑ ¿ì¹°À» ÆÄ¿Ô½À´Ï´Ù. ȨÆäÀÌÁö ³»¿¡ ¼ö¸¹Àº ÄÁÅÙÃ÷µéÀº º» ÀÇ·áÁøÀÇ ¹ßÀÚÃëÀÔ´Ï´Ù. ÀúÈñ´Â °³¿ø ÀÌ·¡ Ç×»ó Á¤Á÷ÇÏ°í Á¤È®ÇÑ Á¤º¸¸¦ µå¸®°íÀÚ ³ë·ÂÇØ ¿Ô½À´Ï´Ù. 20³â µ¿¾È ¼ö¸¹Àº °ËÁõµÇÁö ¾ÊÀº °úÀå ±¤°íµéÀ» ÀúÈñ°¡ ¹Ù·Î Àâ¾Æ ¿Ô°í Áö±Ýµµ Á¤È®ÇÑ Á¤º¸¸¸À» Á¦°øÇÏ°íÀÚ ³ë·ÂÇÏ°í ÀÖ½À´Ï´Ù.

?È®´ë, Á¶·ç ¼ö¼ú ÁßÁ¡ ºñ´¢±â°ú·Î¼­ ÀÌ ¼ö¼úÀ» »ý°¢ÇÏ°í °è½Å ºÐµé²² ´çºÎµå¸³´Ï´Ù. ÀÌ·¸°Ô Áß¿äÇÑ ºÎºÐÀ» ¼ö¼ú¹Þ°íÀÚ ÇÏ½Å´Ù¸é ½Ã°£ÀÌ °É¸®½Å´Ù°í ÇÏ´õ¶óµµ º»¿ø ȨÆäÀÌÁöÀÇ 4M ÄÚ¾î À½°æÈ®´ë¼ú, Ãß°¡ÁøÇÇÁ¶·ç¼ö¼ú¹ý, ÀÚÁÖ¹¯´ÂÁú¹®, ¼ö¼ú ÆÑƮüũ, ¼ö¼ú Èıâ, LJ°ËÁõ°úÁ¤À» Á¤µ¶ÇØ ÁÖ½Ã°í ¼ö¼úÀ» °áÁ¤ÇÏ½Ã±æ ´çºÎµå¸³´Ï´Ù. °¨»çÇÕ´Ï´Ù.
Written by Jang S.Y



ÀÚÁÖ¹¯´ÂÁú¹®
¼ö¼úÆÑƮüũ
ºñ°ø°³»ó´ã
LJÁÖ¿ä¼Ò½Ä
ÀÇÇÐÁ¤º¸¸¸È­
¼ö¼úÈÄ»çÁø
4MÄÚ¾îÈ®´ë¼ö¼ú
LJ Á¶·ç¼ö¼ú¹ý
Àç¹ÌÀ¯À͵¿¿µ»ó
ÀÇ·áÁø¼Ò°³Áø·á¿¹¾àº´¿øÀ§Ä¡&¼Ò°³

¼­¿ï½Ã °­³²±¸ ³íÇöµ¿ 199-5 º¸¶óƼ¾Ëºôµù 8Ãþ
T. 1588-5830
»ç¾÷ÀÚµî·Ï¹øÈ£:211-10-49878|´ëÇ¥ÀÚ:Àå¼ö¿¬
All Right Reserved 2012 ¿¤Á¦À̺ñ´¢±â°úÀÇ¿ø